Delta Auto. (DELTIC)
Fast GrowerScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹48.3 |
| Market Cap | ₹60.7 Cr |
| P/E Ratio | 6.5 |
| ROCE | 23.37% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 20.98% |
| Debt/Equity | — |
| Sales Growth | 36.61% |
| Promoter Holding | 71% |
| 52-Week Range | ₹28.05 — ₹54.8 |
| Sector | Automobiles |
Strengths
- P/E of 6.50 and PEG of 0.23 offer a low valuation relative to the 36.61% sales growth and 20.98% profit growth.
- Promoter holding of 71% aligns majority-owner interests with public shareholders.
- ROCE of 23.37% suggests strong capital efficiency.
- Piotroski F-Score of 7/9 indicates good recent financial health.
- Latest quarter had ₹42 Cr sales and ₹3 Cr net profit, supporting the growth narrative.
Concerns
- Profit growth of 20.98% is significantly lower than sales growth of 36.61%, hinting at margin compression or rising costs.
- Zero dividend yield means shareholders get no income while waiting for growth.
- Book value, ROE and debt/equity are unavailable, so balance-sheet risk and Graham-style asset protection cannot be assessed.
- At ₹48.30, the price is only about 12% below the 52-week high of ₹54.80, and the ₹61 Cr market cap makes it a microcap with limited margin of safety.
AI Analysis
Let me look at Delta Auto the way Graham and I would—starting with the numbers. At ₹48.30, the market caps the company at ₹61 Cr. A P/E of 6.50 is cheap, and with sales growing 36.61%, the PEG ratio of 0.23 screams bargain—if the growth is real. The latest quarter supports some momentum: ₹42 Cr sales and ₹3 Cr net profit. ROCE of 23.37% is exactly the kind of return on capital I like to see. A Piotroski F-score of 7/9 also says the company is not financially deteriorating. Promoter holding of 71% means the people running it own it, which aligns interests with minority shareholders. But I have to be honest: I cannot see a moat from these figures. Two/three wheelers is a competitive, cyclical business in India, and a ₹61 Cr microcap is unlikely to have pricing power. Profit growth of 20.98% lags sales growth of 36.61%, which tells me margins are being squeezed or costs are rising faster. There is no dividend, so I depend entirely on capital appreciation. Also, with book value, ROE and debt/equity not disclosed, I cannot compute Graham's asset-value protection or know how leveraged the balance sheet is. The stock is ₹48.30, just below the 52-week high of ₹54.80, so I am not buying at distressed prices. This is a fast grower, not a cigar-butt; if growth slows, a 6.5 P/E can become a value trap. I would need to see several more quarters of high sales and profit, no debt build-up, and improving margins before calling it a compounder. For now, it passes the cheap-and-growing screen, but I would keep a close watch on execution.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer